Company Profile
Hepregen Corporation
Company Overview
HEPREGEN CORPORATION (Medford, Massachusetts)
Hepregen Corporation (200 Boston Ave, Suite 1500, Medford, MA 02155, www.hepregen.com) is a venture-backed, early stage company focused on commercializing a portfolio of liver tissue engineering technologies out of the Massachusetts Institute of Technology. Hepregen’s mission is to provide innovative bioengineering solutions to the biotech and pharmaceutical industries in order to improve the success and economics of drug development. Its first product (HepatoPac®), a micro-liver platform for advanced toxicity screening and drug discovery, has being adopted by leading drug development organizations and is currently being used across the pharmaceutical industry.
Notable Clients
Alnylam Pharmaceuticals, Amgen, AstraZeneca UK, Boehringer Ingelheim , Eli Lilly, Genentech, Hoffman-La Roche, Janssen Pharmaceutica NV, Merck, Novartis, Pfizer, The Hamner Institutes, Vertex Pharmaceuticals
Benefits
Hepregen offers competitive pay, a high growth environment, and a benefits package that includes participation in health, dental and vision care plans; 401(k) retirement plan; life insurance; and disability coverage.